A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
about
The A20-binding protein ABIN-2 exerts unexpected function in mediating transcriptional coactivationA20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.ROS-induced ZNF580 expression: a key role for H2O2/NF-κB signaling pathway in vascular endothelial inflammationFailure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient miceRegulation and cellular roles of ubiquitin-specific deubiquitinating enzymesThe zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABINTemporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injuryMolecular Basis for the Unique Deubiquitinating Activity of the NF-κB Inhibitor A20Immune-mediated vascular injury and dysfunction in transplant arteriosclerosisThe zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspasesIdentification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2The promyelocytic leukemia protein represses A20-mediated transcriptionZinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantationA20 deficiency causes spontaneous neuroinflammation in miceThe zinc finger protein A20 targets TRAF2 to the lysosomes for degradationVascular injury post stent implantation: different gene expression modulation in human umbilical vein endothelial cells (HUVECs) modelNuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2Genetic analysis of a mouse cross implicates an anti-inflammatory gene in control of atherosclerosis susceptibility.Gene therapy and heart transplantation.A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation.O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis.The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells.TNFalpha-induced macrophage death via caspase-dependent and independent pathways.Ca2+ influx via TRPC channels induces NF-kappaB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells.A20 modulates lipid metabolism and energy production to promote liver regenerationElevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory responseHepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascadesCancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells.A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression.Molecular biomarkers of vascular dysfunction in obstructive sleep apnea.Protein kinase C beta mediates CD40 ligand-induced adhesion of monocytes to endothelial cells.NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression.Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis C.Genetic framework for GATA factor function in vascular biology.A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes
P2860
Q24302016-B9130792-6D0E-4511-A582-84F98EEBEA2AQ24304048-2F77C961-8A20-45F5-84A2-688CF8E4B3ACQ24321338-5B630A45-6B2D-4883-9666-98759F84A438Q24616207-08C25322-2E93-4163-940E-FDB3736ABD5BQ24645701-E464F1AD-EE49-47CB-A9A8-D508AE58430BQ24682087-3E069D7F-4E90-4287-BEA2-3AA786A58657Q27301022-D738D781-26CA-444A-81FF-5F1CB6AFE711Q27649460-DD1479E5-1DB2-4765-8200-F5259137C82AQ28084366-AC56DDE9-3858-4CF8-AA9C-9ADF5EA87E96Q28116163-CA07D9FE-AAE3-43F5-994E-B6E0B402E74FQ28199348-076990D8-D0C0-469D-B094-42C8FACC793EQ28206387-283B87B4-2961-4A30-BA31-D915BBEF4987Q28390590-19D95813-B14D-43EA-AA49-50D898185C3EQ28392084-5B2E7FC2-E1D3-43F0-A2AE-14903527685DQ28509686-34B22BC8-D8C4-46D2-AF05-445C65216B87Q28540164-83A031B6-E49F-42B6-863C-D37B3CA2EB63Q28568258-57544C8A-9606-4F48-954E-1C3D9FBFA82FQ30274938-873FE43E-9B32-40E1-8372-DF8DB2568762Q30482135-5F1197CD-5D7B-4659-92AF-568FCB5226C0Q30826185-1061B838-8FD8-43EC-AB42-B8052C2001C2Q30993051-1B5B8B85-7C92-400B-9FBA-A56782110DE4Q33183441-821812CB-8349-449C-A0D6-0312EDB610E2Q33266888-E95DF6E6-C58F-476A-A1C8-86AAFED46CFDQ33400786-C0B83225-F2E4-4E6A-BA31-C0C86ED15DADQ33727637-7636CF5A-37FC-494A-B974-B54924075D36Q33855522-3EFCA9A5-F4C1-4ED0-895E-04736BCA6BC1Q33889005-6B3C1A1F-4228-4A78-80B7-87A4EB77762FQ33913784-4ACAE1FB-54C2-40CF-BFC3-1A946A58B362Q33922885-262012B6-69AD-4BBF-A657-15FC91E97A56Q34101748-D9958AC9-78F9-49AD-9B3D-AEF0FB152D20Q34127817-3A94DE45-A829-4F45-A427-57642F2F777DQ34467421-2E2493CA-FB8F-4636-B3AC-234DB66E3B6BQ34555267-0BE1AD83-3DED-4066-8753-B39670ACCC2EQ34907105-F1993937-4605-4286-A8F8-48144AC2DC11Q34988499-C3082898-51D8-4A58-9686-2D39305A9585Q35099706-B6C02E96-E7E2-4133-9FA7-5C378E457FDFQ35106240-B235F8BA-B1B9-421A-B5C8-233A0C098326Q35112598-248E3A71-DDDD-4278-A1FC-9BC58D107D2AQ35170673-28983E7C-19C6-475F-87E8-D42C185931C5Q35555093-A4725C0E-D674-4F52-84CC-999C5BEC73BC
P2860
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@ast
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@en
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@nl
type
label
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@ast
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@en
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@nl
prefLabel
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@ast
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@en
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@nl
P2093
P356
P1476
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
@en
P2093
A Palmetshofer
D M Stroka
J T Cooper
P304
18068-18073
P356
10.1074/JBC.271.30.18068
P407
P577
1996-07-01T00:00:00Z